 Connection
Ivor Douglas to Anti-Infective Agents
This is a "connection" page, showing publications Ivor Douglas has written about Anti-Infective Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.224 |
|
|
|
-
Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, G?rdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012 May 31; 366(22):2055-64.
Score: 0.083
-
Finfer S, Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, G?rdlund B, Marshall JC, Rhodes A. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med. 2008 Nov; 34(11):1935-47.
Score: 0.064
-
Levi M, Levy M, Williams MD, Douglas I, Artigas A, Antonelli M, Wyncoll D, Janes J, Booth FV, Wang D, Sundin DP, Macias WL. Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated). Am J Respir Crit Care Med. 2007 Sep 01; 176(5):483-90.
Score: 0.059
-
Thompson BT, Ranieri VM, Finfer S, Barie PS, Dhainaut JF, Douglas IS, G?rdlund B, Marshall JC, Rhodes A. Statistical analysis plan of PROWESS SHOCK study. Intensive Care Med. 2010 Nov; 36(11):1972-3.
Score: 0.018
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|